BioSpace News Archive

HeartBeam, Inc. today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its HeartBeam AIMIGo™ System.

iTolerance, Inc. announced that it has entered into a research collaboration agreement with Israeli-based company, Kadimastem, to co-develop and commercialize a breakthrough and innovative regenerative technology to cure diabetes without the need for chronic immunosuppression.

Fractyl Health today presented key findings from its preclinical Rejuva® program at the American Society of Gene & Cell Therapy (ASGCT) Congress.

The group of Dr. Matteo Bellone, group leader of the Cellular immunology Unit at San Raffaele University & Research Hospital, has shown that Prevotella melaninogenica,

Pacylex Pharmaceuticals, a clinical-stage company developing PCLX-001, a first-in-class oral investigational small molecule for leukemia, lymphoma, and solid tumor cancers, today announced the first patient has been dosed in a Phase 2a expansion study in patients with relapsed/refractory B-cell Non-Hodgkin Lymphoma (R/R NHL).

Rejuvenate Bio, announced new data for its gene therapy RJB-01 from a pilot study in canines with myxomatous mitral valve disease, at the 26th Annual Meeting of the American Society of Gene and Cell Therapy, held May 16-20, 2023, in Los Angeles, California.

This Sunday at 2:37 p.m. PDT1, astronauts from Axiom Space in partnership with Cedars-Sinai will blast off to the International Space Station carrying cells from the Allen Institute for Cell Science, a division of the Allen Institute.

Phio Pharmaceuticals Corp. (Nasdaq: PHIO) today announced pre-clinical data demonstrating that using INTASYL to silence TIGIT and CBL-B may be used to improve the anti-tumor response of NK cells, creating a more effective cell therapy for treating cancer.

RNAimmune, a biotech company focused on developing groundbreaking mRNA therapies, recently received FDA approval to begin Phase 1 clinical studies for an investigational new drug.

Glidewell announced a new partnership with LuxCreo, a leading 3D printing company in dental appliances based in San Francisco, to introduce the fastprint.io™ 3D Printing Solution.